{"id":22950,"date":"2017-04-29T09:00:52","date_gmt":"2017-04-29T07:00:52","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=22950"},"modified":"2017-04-28T13:20:47","modified_gmt":"2017-04-28T11:20:47","slug":"preomics-receives-license-for-proteomics-technology","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/22950\/preomics-receives-license-for-proteomics-technology\/","title":{"rendered":"PreOmics receives license for proteomics technology"},"content":{"rendered":"<div class=\"entry-content\"><p><strong>The Munich startup <a href=\"\/en\/ecosystem\/preomics\/\" target=\"_blank\">PreOmics <\/a>Max Planck Innovation has licensed several technologies from the Max Planck Institute of Biochemistry in Martinsried for sample preparation for proteomics research. With the help of a novel sample preparation kit, scientists will be able to more easily use mass spectrometry for protein research in the future. This, in turn, could open up new possibilities for drug development and diagnostics.<br \/>\n<\/strong><\/p>\n<p>Proteins perform numerous important functions in the human body and are considered the building blocks of life. However, they can also be responsible for the development of a wide variety of diseases, such as cancer, infectious diseases, or Alzheimer&#039;s. To gain insights into the functioning of proteins, identify connections, and develop new therapeutic approaches, research into proteins is being conducted worldwide. <strong>the so-called proteomics<\/strong> \u2013 strongly promoted.<\/p>\n<h3>Goal of proteomics: Deciphering protein malfunctions<\/h3>\n<p>A major hurdle in this field of research is the high complexity of proteins. The human body contains up to a million proteins, which are produced by thousands of different genes. In addition, the protein pattern (proteome; i.e. the totality of all proteins in a cell or living organism) is subject to constant change, as new proteins are synthesized and old proteins are degraded or modified. The aim of proteomics is, among other things, to decipher protein malfunctions. New findings can, for example, be used to develop innovative medications. This way, targeted pharmacological agents can be developed that dock onto disease-causing proteins and prevent malfunctions there. Furthermore, interactions between active ingredients and proteins, as well as possible side effects, can be investigated. New diagnostic tools based on the analysis of protein-protein interactions can also be developed with the help of proteomics.<\/p>\n<p>PreOmics has now developed a standardized sample preparation kit for the first time. It is designed to simplify mass spectrometry. The kit offers a complete, rapid, and easy-to-use solution in a standardized container.<\/p>\n<h3>\u201cKit reduces the number of necessary steps from 10 to 3\u201d<\/h3>\n<p>With the technology, which was developed at the Max Planck Institute of Biochemistry in Matthias Mann&#039;s department, researchers can prepare samples for their analyses much more quickly.<\/p>\n<blockquote><p>&quot;Our sample preparation kit enables robust, reproducible, and rapid sample preparation. The kit reduces the number of necessary steps from 10 to 3. All steps are performed in a special vessel that minimizes potential contamination and is also applicable for high-throughput applications. This allows even non-experts to use mass spectrometry and proteomics, especially for basic research. In the future, use in drug development and diagnostics is also conceivable.&quot;<\/p><\/blockquote>\n<p>so <strong>Nils A. Kulak<\/strong>, co-inventor and co-founder of PreOmics.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based startup PreOmics has licensed several technologies from the Max Planck Institute of Biochemistry in Martinsried for sample preparation for proteomics research from Max Planck Innovation. With the help of a novel sample preparation kit, scientists will be able to more easily use mass spectrometry for protein research in the future. This, in turn, will open up new possibilities for drug development and...<\/p>","protected":false},"author":24,"featured_media":11156,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[1863],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik - Munich Startup<\/title>\n<meta name=\"description\" content=\"PreOmics lizenziert von Max-Planck-Innovation mehrere Technologien des Max-Planck-Instituts f\u00fcr Biochemie zur Probenvorbereitung f\u00fcr die Proteomforschung.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/22950\/preomics-receives-license-for-proteomics-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"PreOmics lizenziert von Max-Planck-Innovation mehrere Technologien des Max-Planck-Instituts f\u00fcr Biochemie zur Probenvorbereitung f\u00fcr die Proteomforschung.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/22950\/preomics-receives-license-for-proteomics-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-29T07:00:52+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/\",\"url\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/\",\"name\":\"PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png\",\"datePublished\":\"2017-04-29T07:00:52+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"PreOmics lizenziert von Max-Planck-Innovation mehrere Technologien des Max-Planck-Instituts f\u00fcr Biochemie zur Probenvorbereitung f\u00fcr die Proteomforschung.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png\",\"width\":897,\"height\":239,\"caption\":\"PreOmics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png\" \/>\n\t<meta property=\"og:image:width\" content=\"897\" \/>\n\t<meta property=\"og:image:height\" content=\"239\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PreOmics receives license for proteomics technology - Munich Startup","description":"PreOmics licenses several technologies from the Max Planck Institute of Biochemistry for sample preparation for proteomics research from Max Planck Innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/22950\/preomics-receives-license-for-proteomics-technology\/","og_locale":"en_US","og_type":"article","og_title":"PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik - Munich Startup","og_description":"PreOmics lizenziert von Max-Planck-Innovation mehrere Technologien des Max-Planck-Instituts f\u00fcr Biochemie zur Probenvorbereitung f\u00fcr die Proteomforschung.","og_url":"https:\/\/cms.munich-startup.net\/en\/22950\/preomics-receives-license-for-proteomics-technology\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2017-04-29T07:00:52+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/","url":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/","name":"PreOmics receives license for proteomics technology - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png","datePublished":"2017-04-29T07:00:52+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"PreOmics licenses several technologies from the Max Planck Institute of Biochemistry for sample preparation for proteomics research from Max Planck Innovation.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png","width":897,"height":239,"caption":"PreOmics"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/22950\/preomics-erhaelt-lizenz-fuer-proteomik-technik\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"PreOmics erh\u00e4lt Lizenz f\u00fcr Proteomik-Technik"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":897,"height":239,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/05\/Logo-PreOmics-2016-e1493377531826.png","type":"image\/png"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1493379861:24","_edit_last":"3","_yoast_wpseo_focuskw":"PreOmics","_yoast_wpseo_metadesc":"PreOmics lizenziert von Max-Planck-Innovation mehrere Technologien des Max-Planck-Instituts f\u00fcr Biochemie zur Probenvorbereitung f\u00fcr die Proteomforschung.","_yoast_wpseo_linkdex":"87","_thumbnail_id":"11156","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"PreOmics","_yoast_wpseo_content_score":"30","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/22950"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=22950"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/22950\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/11156"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=22950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=22950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=22950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}